statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Predicitive Oncology Stock Is Soaring

Predictive Oncology shares are blasting higher Thursday after the company announced it is expanding its AI and machine learning driven drug discovery platform to pursue discovery of novel biomarkers...

Why Predictive Oncology (POAI) Stock Is Skyrocketing

Predictive Oncology shares are trading higher by 46.6% during Tuesday's session. The company announced positive results from a retrospective study conducted with UPMC Magee-Womens Hospital.
read more...

Q4 2023 Predictive Oncology Inc Earnings Call Transcript

Predictive Oncology GAAP EPS of -$3.48, revenue of $1.78M

Predictive Oncology GAAP EPS of -$3.48, revenue of $1.78M...

POAI Stock Earnings: Predictive Oncology Reported Results for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Predictive Oncology just reported results for the fourth quarter of 2023.
The post POAI Stock Earnings: Predictive Oncology Reported...

Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update

Company to host investor call and webcast on Monday, April 1st, at 8:30am EDTPITTSBURGH, March 28, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging...

Predictive Oncology to Participate in Upcoming Investor Conferences

PITTSBURGH, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that Raymond F. Vennare, Chief Executive...

Short Interest in Predictive Oncology Inc. (NASDAQ:POAI) Decreases By 8.3%

Predictive Oncology Inc. (NASDAQ:POAI  Get Free Report) saw a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 32,200...

Predictive Oncology (NASDAQ:POAI) Stock Passes Above 50 Day Moving Average of $3.15

Predictive Oncology Inc. (NASDAQ:POAI  Get Free Report)s share price passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $3.15 and...

Predictive Oncology to Participate in Upcoming San Francisco Conferences

PITTSBURGH, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that Raymond F. Vennare, Chief Executive...

Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal, and associated products. It operates through the following segments: Helomics, zPREDICTA, Skyline, Soluble, and Corporate. The Helomics segment includes contract services that include the application of AI, partnering projects, and clinical testing. The zPREDICTA segment specializes in organ-specific disease models that provide 3D reconstruction of human tissues accurately representing each disease state and mimicking drug response enabling accurate testing of anticancer agents. The Skyline segment is composed of the STREAMWAY System product sales, and its TumorGenesis subsidiary is included within the Corporate segment. The Soluble segment provides services using an automated system that conducts self-interaction chromatography screens, using additives and excipients commonly included in protein formulations resulting in soluble and physically stable formulations for biologics. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Pittsburgh, PA.

Volume	6.01M
52-Wk High	$5.94
52-Wk Low	$0.894

POAI Predictive Oncology Inc

About

Feed

News

Earnings

Fundamentals